Standout Papers
- The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (1996)
- DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study (2015)
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease (1998)
Immediate Impact
2 by Nobel laureates 16 from Science/Nature 84 standout
Citing Papers
Psychedelics reopen the social reward learning critical period
2023 StandoutNature
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Works of Lawrence Friedhoff being referenced
Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability
2014
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
1998 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lawrence Friedhoff | 1477 | 544 | 1529 | 1108 | 54 | 3.8k | |
| Samantha Rogers | 1308 | 277 | 1555 | 787 | 37 | 3.0k | |
| Kimberly Schafer | 934 | 623 | 1488 | 1843 | 38 | 4.6k | |
| Ara S. Khachaturian | 813 | 696 | 1347 | 1704 | 47 | 4.1k | |
| Shelia Jin | 885 | 382 | 1230 | 1450 | 27 | 3.8k | |
| Jacqueline Birks | 1572 | 799 | 1913 | 1457 | 95 | 8.3k | |
| Rupert McShane | 1374 | 365 | 2244 | 1006 | 95 | 5.1k | |
| Albrecht Stöffler | 954 | 597 | 959 | 1038 | 18 | 3.2k | |
| Shobha Dhadda | 1060 | 838 | 1493 | 2392 | 66 | 4.9k | |
| Roger Lane | 2340 | 682 | 2163 | 1306 | 109 | 6.2k | |
| Hong Liu‐Seifert | 1020 | 402 | 1498 | 1641 | 53 | 3.5k |
All Works
Loading papers...